Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail BinnewiesDepartment of Pathology, University of California, San Francisco, San Francisco, CA, USAEdward W. RobertsDepartment of Pathology, University of California, San Francisco, San Francisco, CA, USAKelly KerstenDepartment of Pathology, University of California, San Francisco, San Francisco, CA, USAVincent ChanUCSF Immunoprofiler Initiative, University of California, San Francisco, San Francisco, CA, USADouglas F. FearonCold Spring Harbor Laboratory, Cold Spring Harbor, NY, USAMiriam MéradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USALisa M. CoussensDepartment of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR, USADmitry I. GabrilovichThe Wistar Institute, Philadelphia, PA, USASuzanne Ostrand‐RosenbergDepartment of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD, USACatherine C. HedrickDivision of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USARobert H. VonderheideDepartment of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USAMikaël J. PittetCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USARakesh K. JainEdwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAWeiping ZouDepartment of Surgery, University of Michigan School of Medicine, Ann Arbor, MI, USAT. Kevin HowcroftElisa C. WoodhouseRobert A. WeinbergWhitehead Institute for Biomedical Research, Cambridge, MA, USA. [email protected]Matthew F. KrummelDepartment of Pathology, University of California, San Francisco, San Francisco, CA, USA. [email protected]
2018en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 4Использованных источников: 0